Genital Herpes Treatment Market Genital Herpes Treatment Market Growth and Segments,2016-2026
Future Market Insights has announced the addition of the “Genital Herpes Treatment Market: Global Industry Analysis and Opportunity Assessment 2016-2026” report to their offering.
Future Market Insights has announced the addition of the “Genital Herpes Treatment Market: Global Industry Analysis and Opportunity Assessment 2016-2026” report to their offering.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Genital</strong> <strong>Herpes</strong><br />
<strong>Treatment</strong> <strong>Market</strong><br />
Share, Global Trends,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation <strong>and</strong> Forecast,<br />
<strong>2016</strong>-<strong>2026</strong><br />
Future <strong>Market</strong> Insights<br />
www.futuremarketinsights.com<br />
sales@futuremarketinsights.com
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, <strong>and</strong> consulting<br />
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />
technology inputs, valuable growth insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, <strong>and</strong><br />
Retail.<br />
We have a global presence with delivery centers across India specializing in providing global research reports <strong>and</strong> country<br />
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.<br />
We combine our knowledge <strong>and</strong> learning from every corner of the world to distill it to one thing – the perfect solution for<br />
our client.<br />
Research Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
Sector Coverage<br />
• Automotive <strong>and</strong> Transportation<br />
• Electronics, Semiconductor, <strong>and</strong> ICT<br />
• Retail <strong>and</strong> Consumer Products<br />
• Industrial Automation <strong>and</strong> Equipment<br />
• Chemicals & Materials<br />
• Food <strong>and</strong> Beverages<br />
• Services <strong>and</strong> Utilities<br />
• Energy, Mining, Oil, <strong>and</strong> Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com
Report Description<br />
General herpes is a sexually transmitted infection (STI), caused by herpes simplex virus. It<br />
causes painful blisters on the genital organs <strong>and</strong> surrounding areas of both men <strong>and</strong> women.<br />
It also affects mucus membrane present in the body. Prevalence rate of genital herpes is high<br />
in women when compared with men. <strong>Genital</strong> herpes is a chronic condition <strong>and</strong> it is not<br />
having any cure, however, medication is available to reduce triggered symptoms of the<br />
disease. The viral infection is permanent in human body <strong>and</strong> will become active <strong>and</strong> causes<br />
painful blisters occasionally in first two years. The average rate of recurrence is five times in a<br />
first two years <strong>and</strong> the rate of recurrence will decrease in each time. Prevalence rate of this<br />
disease is high in population with age from 20 to 24 years. It also causes severe health<br />
problems in a pregnant women.<br />
<strong>Treatment</strong> methods include initial treatment, intermittent treatment <strong>and</strong> suppressive<br />
treatment. Antiviral drugs are usually prescribed for seven to ten days in the initial treatment.<br />
In an intermittent therapy, treatment was prescribed depend on the symptoms patient such<br />
as cold sores. In a suppressive therapy, based on the symptoms patients has to take<br />
medication every day. Drugs include acyclovir, famciclovir, <strong>and</strong> Val acyclovir are prescribed for<br />
genital herpes therapy <strong>and</strong> based on the condition drugs are given to patient orally <strong>and</strong><br />
intravenously.<br />
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/repgb-1390<br />
<strong>Genital</strong> <strong>Herpes</strong> <strong>Treatment</strong> <strong>Market</strong>: Drivers <strong>and</strong> Restraints<br />
According to center for disease control <strong>and</strong> prevention approximately 50 million population
Report Description<br />
affected with genital herpes in the U.S. Raising prevalence rate of herpes simplex virus,<br />
insecure sexual contacts are the major factors deriving the growth of genital herpes<br />
treatment market. Moreover, increasing awareness about sexually transmitted diseases <strong>and</strong><br />
raising awareness about healthcare drives the genital herpes treatment market.<br />
<strong>Genital</strong> <strong>Herpes</strong> <strong>Treatment</strong> <strong>Market</strong>: Segmentation<br />
<strong>Genital</strong> <strong>Herpes</strong> <strong>Treatment</strong> <strong>Market</strong> is segmented into product type, distribution channel <strong>and</strong><br />
region<br />
Based on genital herpes product type, the global genital herpes treatment market is<br />
segmented into:<br />
•Acyclovir<br />
•Famciclovir<br />
•Valacyclovir<br />
Based on genital herpes treatment distribution channel, the global genital herpes treatment<br />
market is segmented into:<br />
•Hospital Pharmacies<br />
•General Pharmacies<br />
•Drug stores
Report Description<br />
<strong>Genital</strong> <strong>Herpes</strong> <strong>Treatment</strong> <strong>Market</strong>: Overview<br />
Increasing healthcare awareness among mass population along with rise in prevalence rate<br />
of genital herpes is expected to propel the overall dem<strong>and</strong> for <strong>Genital</strong> <strong>Herpes</strong> <strong>Treatment</strong><br />
worldwide. The market is expected to witness a healthy growth over the forecast period<br />
(<strong>2016</strong>-<strong>2026</strong>)<br />
<strong>Genital</strong> <strong>Herpes</strong> <strong>Treatment</strong> <strong>Market</strong>: Region- wise Outlook<br />
Depending on geographic regions, the global genital herpes treatment market is segmented<br />
into seven key regions: North America, Latin America, Eastern Europe, Western Europe, <strong>and</strong><br />
Asia Pacific excluding Japan, Japan <strong>and</strong> Middle East & Africa. North America is expected to be<br />
the most dominant region for genital herpes treatment during the forecast period, owing<br />
strong healthcare setup <strong>and</strong> people having good awareness about STI diseases. However,<br />
Asia Pacific region is expected to exp<strong>and</strong> at remarkable CAGR in genital herpes treatment<br />
market due to increasing healthcare awareness <strong>and</strong> favorable policies implemented by the<br />
government to start-up companies.<br />
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1390<br />
<strong>Genital</strong> <strong>Herpes</strong> <strong>Treatment</strong> <strong>Market</strong>: Key Players<br />
Some of the key players in this market are Teva Pharmaceuticals Inc., GlaxoSmithKline,<br />
Ranbaxy Laboratories Ltd., Mylan Pharmaceuticals Inc., Hospira Inc., Apotheca Inc., Novartis<br />
AG, Novopharm Ltd., Dr Reddys Laboratories Ltd., S<strong>and</strong>oz Inc. <strong>and</strong> others.
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705
Change language